These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37348610)

  • 1. Anxiolytic-like effects of an mGluR 5 antagonist and a mGluR 2/3 agonist, and antidepressant-like effects of an mGluR 7 agonist in the chick social separation stress test, a dual-drug screening model of treatment-resistant depression.
    White SW; Squires GD; Smith SJ; Wright GM; Sufka KJ; Rimoldi JM; Gadepalli RS
    Pharmacol Biochem Behav; 2023 Jun; 227-228():173588. PubMed ID: 37348610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a treatment-resistant, ketamine-sensitive genetic line in the chick anxiety-depression model.
    Sufka KJ; White SW
    Pharmacol Biochem Behav; 2013 Nov; 113():63-7. PubMed ID: 24157688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending the Specificity of DRL 72-s Behavior for Screening Antidepressant-Like Effects of Glutamatergic Clinically Validated Anxiolytic or Antidepressant Drugs in Rats.
    Marek GJ; Salek AA
    J Pharmacol Exp Ther; 2020 Jul; 374(1):200-210. PubMed ID: 32265323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
    Engin E; Treit D; Dickson CT
    Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group III mGlu receptor agonists produce anxiolytic- and antidepressant-like effects after central administration in rats.
    Pałucha A; Tatarczyńska E; Brański P; Szewczyk B; Wierońska JM; Kłak K; Chojnacka-Wójcik E; Nowak G; Pilc A
    Neuropharmacology; 2004 Feb; 46(2):151-9. PubMed ID: 14680755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluoxetine attenuates the anxiolytic effects of the probiotic VSL#3 in a stress-vulnerable genetic line of aves in the chick social-separation stress test, a dual screening assay.
    White SW; Callahan H; Smith SJ; Padilla FM
    Pharmacol Biochem Behav; 2024 Dec; 245():173880. PubMed ID: 39277109
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
    Pałucha-Poniewiera A; Podkowa K; Rafało-Ulińska A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul; 109():110239. PubMed ID: 33400944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats.
    Pałucha-Poniewiera A; Szewczyk B; Pilc A
    Neuropharmacology; 2014 Jul; 82():59-68. PubMed ID: 24631968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
    Koike H; Chaki S
    Behav Brain Res; 2014 Sep; 271():111-5. PubMed ID: 24909673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant, anxiolytic and procognitive effects of subacute and chronic ketamine in the chronic mild stress model of depression.
    Papp M; Gruca P; Lason-Tyburkiewicz M; Willner P
    Behav Pharmacol; 2017 Feb; 28(1):1-8. PubMed ID: 27759570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice.
    Pomierny-Chamioło L; Poleszak E; Pilc A; Nowak G
    Pharmacol Rep; 2010; 62(6):1186-90. PubMed ID: 21273676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical and raphe GABA
    Pham TH; Defaix C; Nguyen TML; Mendez-David I; Tritschler L; David DJ; Gardier AM
    Pharmacol Biochem Behav; 2020 May; 192():172913. PubMed ID: 32201299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
    Witkin JM; Monn JA; Schoepp DD; Li X; Overshiner C; Mitchell SN; Carter G; Johnson B; Rasmussen K; Rorick-Kehn LM
    J Pharmacol Exp Ther; 2016 Jul; 358(1):71-82. PubMed ID: 27189960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats.
    Podkowa K; Pochwat B; Brański P; Pilc A; Pałucha-Poniewiera A
    Psychopharmacology (Berl); 2016 Aug; 233(15-16):2901-14. PubMed ID: 27286960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine treatment involves medial prefrontal cortex serotonin to induce a rapid antidepressant-like activity in BALB/cJ mice.
    Pham TH; Mendez-David I; Defaix C; Guiard BP; Tritschler L; David DJ; Gardier AM
    Neuropharmacology; 2017 Jan; 112(Pt A):198-209. PubMed ID: 27211253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the anxiety-depression continuum in chicks.
    Warnick JE; Huang CJ; Acevedo EO; Sufka KJ
    J Psychopharmacol; 2009 Mar; 23(2):143-56. PubMed ID: 18515452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of Sceletium tortuosum (L.) N.E. Br. extract fraction in the chick anxiety-depression model.
    Carpenter JM; Jourdan MK; Fountain EM; Ali Z; Abe N; Khan IA; Sufka KJ
    J Ethnopharmacol; 2016 Dec; 193():329-332. PubMed ID: 27553978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mGluR7 allosteric agonist AMN082 produces antidepressant-like effects by modulating glutamatergic signaling.
    Bradley SR; Uslaner JM; Flick RB; Lee A; Groover KM; Hutson PH
    Pharmacol Biochem Behav; 2012 Mar; 101(1):35-40. PubMed ID: 22138407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mGlu5 receptor antagonist MPEP activates specific stress-related brain regions and lacks neurotoxic effects of the NMDA receptor antagonist MK-801: significance for the use as anxiolytic/antidepressant drug.
    Inta D; Filipovic D; Lima-Ojeda JM; Dormann C; Pfeiffer N; Gasparini F; Gass P
    Neuropharmacology; 2012 Apr; 62(5-6):2034-9. PubMed ID: 22261382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats.
    Pałucha-Poniewiera A; Podkowa K; Pilc A
    Behav Pharmacol; 2019 Sep; 30(6):471-477. PubMed ID: 30724804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.